{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:04:44Z","timestamp":1793851484246,"version":"4.6.1"},"reference-count":40,"publisher":"American Society of Hematology","issue":"14","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Humoral antiplatelet factors, such as autoantibodies, are thought to primarily clear platelets by triggering macrophage phagocytosis in immune thrombocytopenia (ITP). However, there are few studies characterizing the capacity and mechanisms of humoral factor\u2013triggered macrophage phagocytosis of platelets using specimens from patients with ITP. Here, we assessed sera from a cohort of 24 patients with ITP for the capacity to trigger macrophage phagocytosis of normal donor platelets and characterized the contribution of humoral factors to phagocytosis. Sera that produced a phagocytosis magnitude greater than a normal human serum mean\u00a0+ 2 standard deviations were considered phagocytosis-positive. Overall, 42% (8\/19) of MHC I alloantibody-negative ITP sera were phagocytosis-positive. The indirect monoclonal antibody immobilization of platelet antigens assay was used to detect immunoglobulin G (IgG) autoantibodies to glycoproteins (GP)IIb\/IIIa, GPIb\/IX, and GPIa\/IIa. Autoantibody-positive sera triggered a higher mean magnitude of phagocytosis than autoantibody-negative sera. Phagocytosis correlated inversely with platelet counts among autoantibody-positive patients but not among autoantibody-negative patients. Select phagocytosis-positive sera were separated into IgG-purified and -depleted fractions via protein G and reassessed for phagocytosis. Phagocytosis was largely retained in the purified IgG fractions. In addition, we assessed serum concentrations of C-reactive protein, serum amyloid P, and pentraxin 3 as potential phagocytosis modulators. Pentraxin 3 concentrations correlated inversely with platelet counts among patients positive for autoantibodies. Taken together, sera from approximately half of the patients with ITP studied triggered macrophage phagocytosis of platelets beyond a normal level. An important role for antiplatelet autoantibodies in phagocytosis is supported; a role for pentraxins such as pentraxin 3 may be suggested.<\/jats:p>","DOI":"10.1182\/bloodadvances.2022009423","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T14:54:18Z","timestamp":1681311258000},"page":"3561-3572","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":16,"title":["Serum from half of patients with immune thrombocytopenia triggers macrophage phagocytosis of platelets"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6480-8821","authenticated-orcid":false,"given":"Peter A. A.","family":"Norris","sequence":"first","affiliation":[{"name":"1Innovation and Portfolio Management, Canadian Blood Services, Toronto, ON, Canada"},{"name":"2Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada"},{"name":"3Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital, Unity Health Toronto, Toronto, ON, Canada"},{"name":"4Toronto Platelet Immunobiology Group, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoya","family":"Tawhidi","sequence":"additional","affiliation":[{"name":"1Innovation and Portfolio Management, Canadian Blood Services, Toronto, ON, Canada"},{"name":"2Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada"},{"name":"3Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital, Unity Health Toronto, Toronto, ON, Canada"},{"name":"4Toronto Platelet Immunobiology Group, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5486-5542","authenticated-orcid":false,"given":"Ulrich J.","family":"Sachs","sequence":"additional","affiliation":[{"name":"5Institute for Clinical Immunology, Transfusion Medicine, and Haemostasis, Justus Liebig University, Giessen, Germany"},{"name":"6Department of Thrombosis and Haemostasis, Giessen University Hospital, Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5297-6406","authenticated-orcid":false,"given":"Christine M.","family":"Cserti-Gazdewich","sequence":"additional","affiliation":[{"name":"1Innovation and Portfolio Management, Canadian Blood Services, Toronto, ON, Canada"},{"name":"2Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada"},{"name":"7Laboratory Medicine Program, University Health Network, Toronto, ON, Canada"},{"name":"8University of Toronto Quality in Utilization, Education and Safety in Transfusion Research Program, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5562-9020","authenticated-orcid":false,"given":"Yulia","family":"Lin","sequence":"additional","affiliation":[{"name":"2Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada"},{"name":"8University of Toronto Quality in Utilization, Education and Safety in Transfusion Research Program, University of Toronto, Toronto, ON, Canada"},{"name":"9Precision Diagnostics and Therapeutics Program, Sunnybrook Health Sciences Centre, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannie","family":"Callum","sequence":"additional","affiliation":[{"name":"1Innovation and Portfolio Management, Canadian Blood Services, Toronto, ON, Canada"},{"name":"8University of Toronto Quality in Utilization, Education and Safety in Transfusion Research Program, University of Toronto, Toronto, ON, Canada"},{"name":"10Department of Pathology and Molecular Medicine, Kingston Health Sciences Centre and Queen\u2019s University, Kingston, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3042-8919","authenticated-orcid":false,"given":"Lazaro","family":"Gil Gonzalez","sequence":"additional","affiliation":[{"name":"3Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital, Unity Health Toronto, Toronto, ON, Canada"},{"name":"4Toronto Platelet Immunobiology Group, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuexin","family":"Shan","sequence":"additional","affiliation":[{"name":"3Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital, Unity Health Toronto, Toronto, ON, Canada"},{"name":"4Toronto Platelet Immunobiology Group, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald R.","family":"Branch","sequence":"additional","affiliation":[{"name":"1Innovation and Portfolio Management, Canadian Blood Services, Toronto, ON, Canada"},{"name":"2Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada"},{"name":"3Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital, Unity Health Toronto, Toronto, ON, Canada"},{"name":"8University of Toronto Quality in Utilization, Education and Safety in Transfusion Research Program, University of Toronto, Toronto, ON, Canada"},{"name":"11Department of Medicine, University of Toronto, Toronto, ON, Canada"},{"name":"12Division of Hematology, Department of Medicine, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5051-6916","authenticated-orcid":false,"given":"Alan H.","family":"Lazarus","sequence":"additional","affiliation":[{"name":"1Innovation and Portfolio Management, Canadian Blood Services, Toronto, ON, Canada"},{"name":"2Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada"},{"name":"3Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital, Unity Health Toronto, Toronto, ON, Canada"},{"name":"4Toronto Platelet Immunobiology Group, Toronto, ON, Canada"},{"name":"8University of Toronto Quality in Utilization, Education and Safety in Transfusion Research Program, University of Toronto, Toronto, ON, Canada"},{"name":"11Department of Medicine, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,7,14]]},"reference":[{"issue":"1","key":"2023072114203386600_bib1","first-page":"1","article-title":"Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura","volume":"38","author":"Harrington","year":"1951","journal-title":"J\u00a0Lab Clin Med"},{"issue":"3","key":"2023072114203386600_bib2","doi-asserted-by":"crossref","first-page":"433","DOI":"10.7326\/0003-4819-38-3-433","article-title":"Immunologic mechanisms in idiopathic and neonatal thrombocytopenic purpura","volume":"38","author":"Harrington","year":"1953","journal-title":"Ann Intern Med"},{"issue":"2","key":"2023072114203386600_bib3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1749-6632.1965.tb18984.x","article-title":"Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic purpura. Physiologic, serologic and isotopic studies","volume":"124","author":"Shulman","year":"1965","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"2023072114203386600_bib4","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3324\/haematol.2020.248385","article-title":"Fc\u03b3RI and Fc\u03b3RIII on splenic macrophages mediate phagocytosis of anti-glycoprotein IIb\/IIIa autoantibody-opsonized platelets in immune thrombocytopenia","volume":"106","author":"Norris","year":"2021","journal-title":"Haematologica"},{"issue":"2","key":"2023072114203386600_bib5","first-page":"16","article-title":"Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP)","volume":"6","author":"Zufferey","year":"2017","journal-title":"J\u00a0Clin Med"},{"key":"2023072114203386600_bib6","doi-asserted-by":"crossref","first-page":"103040","DOI":"10.1016\/j.critrevonc.2020.103040","article-title":"Autologous platelet scintigraphy and clinical outcome of splenectomy in immune thrombocytopenia: a systematic review and meta-analysis","volume":"153","author":"Amini","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"2023072114203386600_bib7","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/bjh.15404","article-title":"Detection of platelet autoantibodies to identify immune thrombocytopenia: state of the art","volume":"182","author":"Porcelijn","year":"2018","journal-title":"Br J Haematol"},{"issue":"4","key":"2023072114203386600_bib8","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1182\/blood.V83.4.1024.1024","article-title":"Spectrum of Ig classes, specificities, and titers of serum antiglycoproteins in chronic idiopathic thrombocytopenic purpura","volume":"83","author":"He","year":"1994","journal-title":"Blood"},{"issue":"5","key":"2023072114203386600_bib9","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/jth.14419","article-title":"The sensitivity and specificity of platelet autoantibody testing in immune thrombocytopenia: a systematic review and meta-analysis of a diagnostic test","volume":"17","author":"Vrbensky","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"issue":"4","key":"2023072114203386600_bib10","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.tmrv.2020.09.003","article-title":"Evolution and utility of antiplatelet autoantibody testing in patients with immune thrombocytopenia","volume":"34","author":"Porcelijn","year":"2020","journal-title":"Transfus Med Rev"},{"key":"2023072114203386600_bib11","doi-asserted-by":"crossref","first-page":"12594773","DOI":"10.3389\/fimmu.2021.594773","article-title":"C-reactive protein enhances IgG-mediated cellular destruction through IgG-Fc receptors in\u00a0vitro","volume":"12","author":"Temming","year":"2021","journal-title":"Front Immunol"},{"issue":"11","key":"2023072114203386600_bib12","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1182\/blood-2014-05-579110","article-title":"C-reactive protein enhances IgG-mediated phagocyte responses and thrombocytopenia","volume":"125","author":"Kapur","year":"2015","journal-title":"Blood"},{"issue":"5","key":"2023072114203386600_bib13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJM197401312900505","article-title":"In\u00a0vitro platelet phagocytosis by splenic leukocytes in idiopathic thrombocytopenic purpura","volume":"290","author":"McMillan","year":"1974","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"2023072114203386600_bib14","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJM197405022901803","article-title":"Phagocytosis of antibody-coated platelets by human granulocytes","volume":"290","author":"Handin","year":"1974","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"2023072114203386600_bib15","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1159\/000206736","article-title":"In\u00a0vitro platelet phagocytosis in idiopathic thrombocytopenic purpura","volume":"70","author":"Tsubakio","year":"1983","journal-title":"Acta Haematol"},{"issue":"5","key":"2023072114203386600_bib16","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-3083.2011.02600.x","article-title":"The isotype of autoantibodies influences the phagocytosis of antibody-coated platelets in autoimmune thrombocytopenic purpura","volume":"74","author":"Hoemberg","year":"2011","journal-title":"Scand J Immunol"},{"issue":"6","key":"2023072114203386600_bib17","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.autrev.2017.04.012","article-title":"Pathogenesis of immune thrombocytopenia","volume":"16","author":"Audia","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"12","key":"2023072114203386600_bib18","doi-asserted-by":"crossref","first-page":"e0278365","DOI":"10.1371\/journal.pone.0278365","article-title":"THP-1 cells transduced with CD16A utilize Fc\u03b3 receptor I and III in the phagocytosis of IgG-sensitized human erythrocytes and platelets","volume":"17","author":"Gil Gonzalez","year":"2022","journal-title":"PLoS One"},{"issue":"6","key":"2023072114203386600_bib19","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1182\/blood.V70.6.1722.1722","article-title":"Monoclonal antibody--specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies","volume":"70","author":"Kiefel","year":"1987","journal-title":"Blood"},{"key":"2023072114203386600_bib40","author":"Norris Peter","year":"2022"},{"issue":"2","key":"2023072114203386600_bib20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/cei.12935","article-title":"Fcgamma receptor expression on splenic macrophages in adult immune thrombocytopenia","volume":"188","author":"Audia","year":"2017","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"2023072114203386600_bib21","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2141.1991.tb04530.x","article-title":"Autoantibodies against platelet glycoprotein Ib\/IX: a frequent finding in autoimmune thrombocytopenic purpura","volume":"79","author":"Kiefel","year":"1991","journal-title":"Br J Haematol"},{"issue":"10","key":"2023072114203386600_bib22","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1182\/blood.V86.10.3789.bloodjournal86103789","article-title":"Extracellular epitopes of platelet glycoprotein Ib alpha reactive with serum antibodies from patients with chronic idiopathic thrombocytopenic purpura","volume":"86","author":"He","year":"1995","journal-title":"Blood"},{"key":"2023072114203386600_bib23","doi-asserted-by":"crossref","first-page":"112126","DOI":"10.3389\/fimmu.2020.02126","article-title":"How C-reactive protein structural isoforms with distinctive bioactivities affect disease progression","volume":"11","author":"Rajab","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"2023072114203386600_bib24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/imr.12350","article-title":"Mouse and human FcR effector functions","volume":"268","author":"Bruhns","year":"2015","journal-title":"Immunol Rev"},{"issue":"5","key":"2023072114203386600_bib25","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1046\/j.1365-2141.2003.04509.x","article-title":"The IgG subclasses of platelet-associated autoantibodies directed against platelet glycoproteins IIb\/IIIa in patients with idiopathic thrombocytopenic purpura","volume":"122","author":"Chan","year":"2003","journal-title":"Br J Haematol"},{"issue":"30","key":"2023072114203386600_bib26","doi-asserted-by":"crossref","first-page":"26733","DOI":"10.1074\/jbc.M202069200","article-title":"Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity","volume":"277","author":"Shields","year":"2002","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"2023072114203386600_bib27","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1038\/s41598-020-59651-7","article-title":"IgG-Fc glycosylation before and after rituximab treatment in immune thrombocytopenia","volume":"10","author":"Schmidt","year":"2020","journal-title":"Sci Rep"},{"issue":"4","key":"2023072114203386600_bib28","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1365-2141.1985.tb07477.x","article-title":"Platelet-associated complement in chronic ITP","volume":"60","author":"Kurata","year":"1985","journal-title":"Br J Haematol"},{"issue":"6","key":"2023072114203386600_bib29","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1182\/blood.V50.6.1129.1129","article-title":"Platelet-bound complement (C3) in immune thrombocytopenia","volume":"50","author":"Hauch","year":"1977","journal-title":"Blood"},{"issue":"5","key":"2023072114203386600_bib30","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1182\/blood.V59.5.1023.1023","article-title":"Platelet-associated complement C3 in immune thrombocytopenic purpura","volume":"59","author":"Myers","year":"1982","journal-title":"Blood"},{"issue":"2","key":"2023072114203386600_bib31","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-0609.2011.01718.x","article-title":"Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP)","volume":"88","author":"Najaoui","year":"2012","journal-title":"Eur J Haematol"},{"issue":"5","key":"2023072114203386600_bib32","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/rth2.12388","article-title":"Serum complement levels in immune thrombocytopenia: characterization and relation to clinical features","volume":"4","author":"Cheloff","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"2023072114203386600_bib33","doi-asserted-by":"crossref","first-page":"92607","DOI":"10.3389\/fimmu.2018.02607","article-title":"Pentraxins and Fc receptor-mediated immune responses","volume":"9","author":"Lu","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"2023072114203386600_bib34","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.semarthrit.2008.03.006","article-title":"The long pentraxin 3 and its role in autoimmunity","volume":"39","author":"Ortega-Hernandez","year":"2009","journal-title":"Semin Arthritis Rheum"},{"key":"2023072114203386600_bib35","doi-asserted-by":"crossref","first-page":"10240","DOI":"10.3389\/fimmu.2019.00240","article-title":"Elevated systemic pentraxin-3 is associated with complement consumption in the acute phase of thrombotic microangiopathies","volume":"10","author":"Trojnar","year":"2019","journal-title":"Front Immunol"},{"issue":"7","key":"2023072114203386600_bib36","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1097\/00003246-200107000-00017","article-title":"Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients","volume":"29","author":"Muller","year":"2001","journal-title":"Crit Care Med"},{"issue":"4","key":"2023072114203386600_bib37","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1515\/CCLM.2009.110","article-title":"Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations","volume":"47","author":"Yamasaki","year":"2009","journal-title":"Clin Chem Lab Med"},{"issue":"11","key":"2023072114203386600_bib38","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1182\/blood.V112.11.3427.3427","article-title":"Autoantibodies in patients with ITP do not bind to patient-specific epitopes on platelet glycoproteins","volume":"112","author":"Smith","year":"2008","journal-title":"Blood"},{"issue":"6","key":"2023072114203386600_bib39","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3324\/haematol.2018.211086","article-title":"Glycoprotein V is a relevant immune target in patients with immune thrombocytopenia","volume":"104","author":"Vollenberg","year":"2019","journal-title":"Haematologica"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/14\/3561\/2065191\/blooda_adv-2022-009423-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/14\/3561\/2065191\/blooda_adv-2022-009423-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T14:26:08Z","timestamp":1689949568000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/14\/3561\/495279\/Serum-from-half-of-patients-with-immune"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,14]]},"references-count":40,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2023,7,25]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2022009423","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,14]]}}}